A dosing study of nonoxynol-9 and genital irritation.
The objective of the study was to assess the symptoms and signs of genital irritation produced by different frequencies of nonoxynol-9 (N-9) use. Thirty-five women were randomized to each of 5 groups and used a vaginal suppository for 2 weeks. Group 1: N-9 once every other day; Group 2: N-9 once a day; Group 3: N-9 twice a day; Group 4: N-9 4 times a day; and Group 5: placebo 4 times a day. Study women were examined at admission, one week and 2 weeks with a colposcope for erythema and epithelial disruption, and were interviewed about vaginal itching and burning. The rates of reported symptoms for N-9 users were not significantly different from that of placebo users. The rate of epithelial disruption for women using N-9 every other day was essentially the same as that of women using placebo. The rates of epithelial disruption for women using N-9 1/day and 2/day were 2.5 times greater than that of placebo users. The rate of epithelial disruption for women using N-9 4/day was five times greater than that of placebo users. Genital irritation was located primarily on the vagina or cervix, and vulvitis was not a significant problem. Women who infrequently use N-9 products may not experience an increase in genital irritation. Women who choose to use N-9 frequently may experience an increase in epithelial disruption.
Roddy
R E
RE
Family Health International, Research Triangle Park, North Carolina 27709.
Cordero
M
M
Cordero
C
C
Fortney
J A
JA
D000293:Adolescent; D000328:Adult; D004293:Dominican Republic; D004334:Drug Administration Schedule; D005260:Female; D005831:Genital Diseases, Female / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D017137:Nonoxynol / Q000008:administration & dosage* / Q000009:adverse effects*; D010570:Pessaries; D010865:Pilot Projects; D014627:Vaginitis / Q000139:chemically induced
D017137:Nonoxynol